DIAGNOS Inc. DGNOF
0.25 USD -0.01 (-3.85%)
At closeNov 10, 2026, 4:00 PM EST
0.24 Day range 0.2537
0.13 52-week range 0.38
- YTD
- -3.85%
- 1 year
- +13.64%
News
globenewswire.com DIAGNOS Provides an Update on Stock Warrants BROSSARD, Quebec, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of…
globenewswire.com DIAGNOS Advances Regulatory Strategy with US FDA Submission for CARA System BROSSARD, Quebec, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of…
globenewswire.com DIAGNOS to Hold its Annual General Meeting of Shareholders on September 30, 2026 BROSSARD, Quebec, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of…
globenewswire.com DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI-Assisted Retinal Image Analysis to Saudi Arabia BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of…
globenewswire.com DIAGNOS Receives Health Canada Medical Device Licence for CARA System, Bringing AI-Assisted Retinal Image Analysis to Canadian Optometrists BROSSARD, Quebec, July 27, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of…
globenewswire.com DIAGNOS to Extend the Exercise Period of Stock Warrants BROSSARD, Quebec, July 07, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical…
globenewswire.com Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform BROSSARD, Quebec, June 05, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of…
globenewswire.com DIAGNOS to Present at the Emerging Growth Conference on June 10, 2026 DIAGNOS invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. BROSSARD, Quebec, June…
globenewswire.com DIAGNOS Announces Amendment to Convertible Debentures BROSSARD, Quebec, May 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical…
globenewswire.com DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA BROSSARD, Quebec, April 08, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of…
globenewswire.com DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration BROSSARD, Quebec, April 01, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of…
defenseworld.net DIAGNOS (OTCMKTS:DGNOF) Trading Up 2.6% – Time to Buy? Shares of DIAGNOS Inc. (OTCMKTS:DGNOF - Get Free Report) shot up 2.6% during trading on Wednesday. The stock traded as high as $0.2145 and last traded at $0.2125. 25,000 shares were traded during…
globenewswire.com DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants BROSSARD, Quebec, March 05, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical…
globenewswire.com DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference BROSSARD, Quebec, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical…
defenseworld.net DIAGNOS (OTCMKTS:DGNOF) Trading 1.6% Higher – Still a Buy? DIAGNOS Inc. (OTCMKTS:DGNOF - Get Free Report)'s share price traded up 1.6% during trading on Tuesday. The company traded as high as $0.2189 and last traded at $0.2175. 300,800 shares were traded…
globenewswire.com DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation BROSSARD, Quebec, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical…
globenewswire.com DIAGNOS Announces the Engagement of IBN BROSSARD, Quebec, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues…
defenseworld.net Head to Head Analysis: DIAGNOS (OTCMKTS:DGNOF) vs. Fathom (NASDAQ:FTHM) Fathom (NASDAQ: FTHM - Get Free Report) and DIAGNOS (OTCMKTS:DGNOF - Get Free Report) are both small-cap business services companies, but which is the better investment? We will contrast the two…
globenewswire.com Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital Not for distribution to United States newswire services or for dissemination in the United States. BROSSARD, Quebec, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Company”) (TSXV:…
defenseworld.net Contrasting DIAGNOS (OTCMKTS:DGNOF) & Priority Technology (NASDAQ:PRTH) Priority Technology (NASDAQ: PRTH - Get Free Report) and DIAGNOS (OTCMKTS:DGNOF - Get Free Report) are both small-cap business services companies, but which is the better stock? We will contrast the…